EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Irreversible shock is not irreversible: a new model of massive hemorrhage and resuscitation



Irreversible shock is not irreversible: a new model of massive hemorrhage and resuscitation



Journal of Trauma 50(5): 826-834



Background: Existing shock models do not address the patient with massive hemorrhage (> 1 blood volume). Such patients often die from irreversible shock. This model simulates the clinical scenario of massive hemorrhage and resuscitation (MHR) to determine if irreversible shock can be reversed. Methods: Lewis rats were bled at a rate of 1 estimated blood volume (EBV) per hour for 2 hours with simultaneous infusion of resuscitation mixture (RM) consisting of red blood cells and crystalloid. Blood pressure was maintained at a mean arterial pressure (MAP) of 50 mm Hg during the 2 hours of hemorrhage. Hemorrhage was stopped and resuscitation continued for 1 hour until 6, 8, or 10 X EBV of RM was infused. Control animals were subjected to a traditional fixed pressure hemorrhage to MAP of 50 mm Hg for 2 hours followed by resuscitation to MAP > 90 mm Hg for 1 hour with crystalloid alone. Two-week survival was compared using a chi2 test. Results: Control animals (n = 13) were hemorrhaged 48% +- 5% of EBV and had a mortality rate of 23%. MHR animals had severity and duration of hypotension identical to that of controls but were hemorrhaged 214% +- 8% of EBV. Despite receiving 390 mL/kg of RM and a final hematocrit of 37%, 14 of 15 animals resuscitated with 6 X EBV died from "irreversible" shock (mortality, 93%; p < 0.001 vs. controls). When very large volumes of resuscitation were used, survival rates improved significantly. The 10 X EBV group received 120% of lost red blood cells and 530 mL/kg of crystalloid and had 64% survival at 2 weeks (p < 0.01 vs. 6 X EBV group). Conclusion: This MHR model is much more lethal than a traditional severe hemorrhage model and reproduces the clinical picture of irreversible shock. This irreversible shock can be reversed with very large volumes of resuscitation.

(PDF emailed within 0-6 h: $19.90)

Accession: 010885756

Download citation: RISBibTeXText

PMID: 11371837

DOI: 10.1097/00005373-200105000-00009



Related references

Parabiotic resuscitation in irreversible hemorrhagic shock. Surgical Forum 17: 17-19, 1966

Resuscitation from irreversible shock by intra-arterial transfusion. Lancet 269(6892): 701-705, 1955

Modeling of irreversible thermal protein denaturation at varying temperature. I. The model involving two consecutive irreversible steps. Biochemistry. Biokhimiia 63(4): 434-440, 1998

Cutaneous and skeletal muscle vascular responses to hemorrhage and irreversible shock. American Journal of Physiology 212(2): 488-497, 1967

Vasopressor therapy using vasopressin prior to crystalloid resuscitation in irreversible hemorrhagic shock under isoflurane anesthesia in dogs. Journal of Veterinary Medical Science 69(5): 459-464, 2007

Irreversible thermic shock in rats: methods and results of a standardized shock model. Journal of International Medical Research 9(1): 21-30, 1981

Reversible and irreversible hemorrhagic shock in rats. Methods and results of a standardized shock model. Beitrage Zur Pathologie 153(4): 339-352, 1974

A new model of massive hemorrhage and resuscitation reveals high lethality and unexpected resuscitation requirements. Clinical & Investigative Medicine 19(4 SUPPL ): S107, 1996

Successful resuscitation of unexpected neonatal hemorrhagic shock due to massive feto-maternal hemorrhage. Paediatric Anaesthesia 18(10): 1004-1006, 2008

Utility of clinical parameters of tissue oxygenation in a quantitative model of irreversible hemorrhagic shock. Shock 10(5): 343-346, 1998

Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species. Journal of Pharmaceutical Sciences 56(5): 660-661, 1967

Irreversible enzyme inhibitors. CLXXV. Irreversible inhibition of purified dihydrofolic reductase. Journal of Medicinal Chemistry 13(6): 1143-1148, 1970

Kinetics of irreversible enzyme inhibition: the Tsou plot in irreversible binding co-operativity. Journal of Theoretical Biology 70(4): 461-465, 1978

Irreversible enzyme inhibitors. 103. 9-(p-Bromoacetamidophenyl)guanine, an irreversible inhibitor of xanthine oxidase. Journal of Medicinal Chemistry 10(6): 1106-1109, 1967

Irreversible enzyme Inhibitors Cm g-fo-BromoacetamidophenylJguanlne, an irreversible Inhibitor of xanthlne oxidase. 1967